225 related articles for article (PubMed ID: 17334662)
1. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.
Kuhle J; Lindberg RL; Regeniter A; Mehling M; Hoffmann F; Reindl M; Berger T; Radue EW; Leppert D; Kappos L
J Neurol; 2007 Feb; 254(2):160-8. PubMed ID: 17334662
[TBL] [Abstract][Full Text] [Related]
2. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
Rauer S; Euler B; Reindl M; Berger T
J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):739-42. PubMed ID: 16705196
[TBL] [Abstract][Full Text] [Related]
3. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
Kuhle J; Pohl C; Mehling M; Edan G; Freedman MS; Hartung HP; Polman CH; Miller DH; Montalban X; Barkhof F; Bauer L; Dahms S; Lindberg R; Kappos L; Sandbrink R
N Engl J Med; 2007 Jan; 356(4):371-8. PubMed ID: 17251533
[TBL] [Abstract][Full Text] [Related]
6. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
[TBL] [Abstract][Full Text] [Related]
8. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes.
Correale J; de los Milagros Bassani Molinas M
J Neuroimmunol; 2003 Mar; 136(1-2):162-71. PubMed ID: 12620656
[TBL] [Abstract][Full Text] [Related]
9. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
Wajgt A; Górny M
Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
[TBL] [Abstract][Full Text] [Related]
10. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
[TBL] [Abstract][Full Text] [Related]
11. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients.
Markovic M; Trajkovic V; Drulovic J; Mesaros S; Stojsavljevic N; Dujmovic I; Mostarica Stojkovic M
J Neurol Sci; 2003 Jul; 211(1-2):67-73. PubMed ID: 12767500
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
[TBL] [Abstract][Full Text] [Related]
14. Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
Klawiter EC; Piccio L; Lyons JA; Mikesell R; O'Connor KC; Cross AH
Arch Neurol; 2010 Sep; 67(9):1102-8. PubMed ID: 20837855
[TBL] [Abstract][Full Text] [Related]
15. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.
Berger T; Rubner P; Schautzer F; Egg R; Ulmer H; Mayringer I; Dilitz E; Deisenhammer F; Reindl M
N Engl J Med; 2003 Jul; 349(2):139-45. PubMed ID: 12853586
[TBL] [Abstract][Full Text] [Related]
16. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
Menon KK; Piddlesden SJ; Bernard CC
J Neurochem; 1997 Jul; 69(1):214-22. PubMed ID: 9202313
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
Xiao BG; Linington C; Link H
J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.
Hellings N; Gelin G; Medaer R; Bruckers L; Palmers Y; Raus J; Stinissen P
J Neuroimmunol; 2002 May; 126(1-2):143-60. PubMed ID: 12020966
[TBL] [Abstract][Full Text] [Related]
19. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]